Price Alert

Vigil Neuroscience Inc. (VIGL)

NASDAQ: VIGL · Real-Time Price · USD

8.05

0.00 (0.00%)

At close: Aug 04, 2025, 3:59 PM

Vigil Neuroscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	41.21M	51.62M	39.02M	44.9M	37.31M	51.76M	51.99M	56.79M	58.74M	95.62M	186.6M	203.86M	148.91M	163.32M	91.42M	110.66M	33.06M	-24.15M
Short-Term Investments	25.77M	35.48M	58.78M	66.37M	49.36M	49.88M	65.95M	76.85M	91.42M	68.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	48.3M
Long-Term Investments	n/a	n/a	n/a	927K	927K	927K	927K	927K	927K	927K	927K	927K	927K	927K	n/a	n/a	n/a	n/a
Other Long-Term Assets	948K	1.07M	1.02M	103K	295K	126K	83K	n/a	n/a	n/a	266K	193K	29K	116K	3.68M	1.85M	37K	-24.15M
Receivables	n/a	412K	599K	395K	530K	1.5M	1.49M	604K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-26.36M	n/a	n/a	10.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.31M	2.64M	2.19M	945K	939K	910K	797K	1.12M	1.18M	1.36M	4.4M	702K	1.22M	468K	359K	225K	53K	n/a
Total Current Assets	70.29M	90.15M	100.58M	113.69M	90.22M	106.54M	121.91M	139.85M	155.72M	172.22M	197.81M	212.94M	155.74M	170.43M	97.48M	111.91M	33.54M	24.15M
Property-Plant & Equipment	15.46M	15.93M	16.09M	16.56M	17.03M	17.48M	17.94M	18.38M	18.76M	19.22M	1.4M	1.45M	1.23M	1.34M	1.27M	655K	635K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	16.41M	17M	17.11M	17.59M	18.25M	18.54M	18.95M	19.31M	19.69M	20.14M	2.59M	2.57M	2.19M	2.39M	4.96M	2.51M	672K	-24.15M
Total Assets	86.7M	107.15M	117.69M	131.27M	108.46M	125.08M	140.86M	159.16M	175.41M	192.36M	200.39M	215.51M	157.93M	172.81M	102.44M	114.42M	34.21M	n/a
Account Payables	1.55M	2.58M	1.97M	860K	1.42M	1.49M	1.95M	1.3M	2.36M	2.17M	1.94M	2.36M	1.73M	2.71M	3.98M	5.1M	4.27M	n/a
Deferred Revenue	n/a	20.01M	20.01M	n/a	n/a	n/a	n/a	7.87M	4.78M	n/a	n/a	n/a	n/a	n/a	4.92M	4.07M	n/a	n/a
Short-Term Debt	1.11M	n/a	n/a	n/a	969K	n/a	905K	874K	804K	1.06M	n/a	381K	541K	734K	n/a	n/a	n/a	n/a
Other Current Liabilities	33.01M	243K	289K	28.68M	5.15M	4.82M	3.7M	-776K	-509K	1.96M	1.8M	3.99M	2.8M	1.6M	659K	63K	148K	n/a
Total Current Liabilities	34.11M	30.4M	34.15M	30.55M	10.76M	8.6M	11.66M	10.14M	8.17M	7.39M	11.31M	9.6M	7.29M	6.6M	9.88M	9.6M	8.77M	n/a
Long-Term Debt	11.33M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	161.94M	161.98M	n/a	n/a
Total Long-Term Liabilities	11.33M	11.62M	11.91M	12.18M	12.44M	12.69M	12.95M	13.18M	13.41M	13.63M	2.12M	2.74M	8K	35K	162M	162.07M	184K	n/a
Total Liabilities	45.44M	42.02M	46.06M	42.72M	23.19M	21.3M	24.61M	23.32M	21.57M	21.02M	11.31M	9.6M	7.3M	6.63M	171.88M	171.67M	8.96M	n/a
Total Debt	12.44M	12.69M	12.95M	13.18M	13.41M	13.63M	13.85M	14.05M	14.21M	14.69M	176K	381K	549K	769K	937K	452K	184K	n/a
Common Stock	5K	5K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	3K	3K	n/a	1K	1K	n/a
Retained Earnings	-356.1M	-329.44M	-307.03M	-283.2M	-263.94M	-242.71M	-222.77M	-200.6M	-180.1M	-159.93M	-140.13M	-121.68M	-104.18M	-87.16M	-71.83M	-58.84M	-48.1M	n/a
Comprehensive Income	1K	19K	27K	110K	-26K	-30K	-5K	-56K	-70K	106K	-0.00	n/a	0.00	-172.81M	n/a	-161.98M	n/a	-28.28M
Shareholders Equity	41.26M	65.12M	71.64M	88.55M	85.27M	103.78M	116.25M	135.84M	153.84M	171.34M	189.08M	205.91M	150.63M	166.18M	-69.44M	-57.26M	25.25M	18.75M
Total Investments	n/a	35.48M	58.78M	66.37M	50.29M	50.81M	66.88M	76.85M	91.42M	68.86M	927K	927K	927K	927K	n/a	n/a	n/a	48.3M